Searchable abstracts of presentations at key conferences in endocrinology

ea0035p182 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Evaluation of lipid levels in familial hypercholesterolemia in a lipid unit

Gonzalez-Molero Inmaculada , Vallejo Rosario , Omiste Antonio , Tinahones Francisco

Objective: To determine the degree of control of hypercholesterolemia in a specific lipid unit.Material and Methods: Retrospective study of patients followed in our unit over the past 16 years diagnosed with heterozygous familial hypercholesterolemia (HFH) or familial combined hyperlipidemia (FCH). Control criteria according to the following recommendations were compared: International Panel (2003), Nice (2008), NLA (2011), ESC / ESA 2011, Consensus ADA ...

ea0032p485 | Diabetes | ECE2013

Efficacy and safety of liraglutide in morbid obese patients in first year of commercialization in Spain

Molero Inmaculada Gonzalez- , Vallejo Rosario , Dominguez Marta , Garcia-Arnes Juan

Aim: To evaluate the efficacy and safety for first patients treated in our clinic with liraglutide.Methods: Retrospective study of patients who started treatment with liraglutide in the last year in our department. We collected data on age, years of evolution, chronic complications, previous treatment, physical examination, analytical parameters and side effects.Results: Fifty-four patients. Follow-up: 4–12 months. Mean age: 5...

ea0035p184 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Features of patients with familial hypercholesterolemia treated in a specific lipid unit

Gonzalez-Molero Inmaculada , Vallejo Rosario , Omiste Antonio , Olveira Gabriel , Tinahones Francisco

Objective: To determine the characteristics of patients with familiar hypercholesterolemia studied in a specific unit of lipids.Material and methods: A descriptive study of patients followed in our unit over the last 16 years diagnosed with heterozygous familial hypercholesterolemia (HFH) or familial combined hyperlipidemia (FCH).Results: Data from 111 patients were analyzed: 66 with HFH and 45 with FCH.Featu...

ea0056gp95 | Diabetes Therapy | ECE2018

Randomized control study to compare security and efficacy of the new long acting analogues degludec and glargina U300 in people with type 1 Diabetes. Preliminary results of the Ineox study

Dominguez-Lopez Marta Elena , Vallejo Rosario , Morillas Virginia , Colomo Natalia , Guerrero Mercedes , Rojo Gema , de Adana Navas Marisol Ruiz

Background: There aren’t published randomized studies comparing the clinical impact of degludec and Glragina U300 in the treatment of type 1 diabetes patients. (T1DP)Objective: To compare efficacy and safety of the new long acting analogues Glargine U 300 and Degludec in 300 Type1 diabetes patients treated with basal/bolus treatment.(BBT)Material and methods: Randomized control study 1.1 in 300 T1DP treated with BBT with glarg...

ea0041ep827 | Obesity | ECE2016

Evaluation of the use of parenteral nutrition premixed bags vs individualized nutrition in our hospital

Gonzalez-Molero Inmaculada , Torralvo Francisco Sanchez , Mora Rosario Vallejo , Gonzalo-Marin Monserrat , Bolivar Victoria Contreras , Fernandez C Gallego , Olveira Gabriel , Tinahones Francisco

Introduction: Parenteral nutrition (PN) is indicated in patients in which gastrointestinal tract is inaccessible or is severely affected. In our hospital, specialists often use commercial three-compartment bags of PN that provide standard nutritional requirements regardless a total parenteral nutrition (TPN) with macro and micronutrients adjusted to each patient by Endocrinology and Nutrition Service.Objectives: To assess the use of commercial premixed P...